FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999444785> ?p ?o ?g. }

• W1999444785 endingPage "2159" @default.
• W1999444785 startingPage "2153" @default.
• W1999444785 abstract "Graves ophthalmopathy (GO) is an autoimmune disorder characterized by increased adipogenesis and hyaluronan (HA) production by orbital fibroblasts. Circulating autoantibodies (thyroid-stimulating antibodies [TSAbs]) directed at the thyrotropin receptor (TSHR) on these cells stimulate or augment these cellular processes. A recently developed drug-like small molecule inverse agonist of TSHR, NCGC00229600, termed 1, binds to TSHR and blocks basal and stimulated signal transduction. The purpose of this article was to determine whether 1 might inhibit HA production and relevant signaling pathways in orbital fibroblasts cultured in the presence of monoclonal TSAbs or bovine TSH (bTSH). Primary cultures of undifferentiated GO orbital fibroblasts (n = 13) were untreated or treated with a TSAb (M22 or MS-1) or bTSH in serum-free medium, with or without 1 or a TSHR neutral antagonist, NCGC00242595, termed 2, which does not inhibit basal signaling but does inhibit stimulated signaling. cAMP production, Akt phosphorylation (Ser473pAkt in media and immunoblotting for pAkt/total Akt), and HA production were analyzed. Compound 1 inhibited basal cAMP, pAkt, and HA production and that stimulated by M22 in undifferentiated orbital fibroblasts. Inhibition of HA production was dose-dependent, with a half-maximal inhibitory dose of 830 nM. This compound also inhibited MS-1- and bTSH-stimulated cAMP, pAkt, and HA production. Compound 2 did not inhibit basal HA production but did inhibit M22-stimulated HA production. Because cAMP, pAkt, and HA production are fibroblast functions that are activated via TSHR signaling and are important in the pathogenesis of GO, small molecule TSHR antagonists may prove to be effective in the treatment or prevention of the disease in the future." @default.
• W1999444785 created "2016-06-24" @default.
• W1999444785 creator A5005079343 @default.
• W1999444785 creator A5035260029 @default.
• W1999444785 creator A5039851000 @default.
• W1999444785 creator A5041657790 @default.
• W1999444785 creator A5042928667 @default.
• W1999444785 creator A5055948934 @default.
• W1999444785 creator A5064422018 @default.
• W1999444785 creator A5091104216 @default.
• W1999444785 date "2013-05-01" @default.
• W1999444785 modified "2023-10-06" @default.
• W1999444785 title "A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy" @default.
• W1999444785 cites W1505110999 @default.
• W1999444785 cites W1991694066 @default.
• W1999444785 cites W1992997083 @default.
• W1999444785 cites W2003491679 @default.
• W1999444785 cites W2030897875 @default.
• W1999444785 cites W2039119197 @default.
• W1999444785 cites W2049828925 @default.
• W1999444785 cites W2051474962 @default.
• W1999444785 cites W2055914198 @default.
• W1999444785 cites W2058466955 @default.
• W1999444785 cites W2081396141 @default.
• W1999444785 cites W2091089626 @default.
• W1999444785 cites W2102471600 @default.
• W1999444785 cites W2123670278 @default.
• W1999444785 cites W2128713083 @default.
• W1999444785 cites W2130294652 @default.
• W1999444785 cites W2146967079 @default.
• W1999444785 cites W2149848264 @default.
• W1999444785 cites W2152928608 @default.
• W1999444785 cites W2153159377 @default.
• W1999444785 cites W4240137178 @default.
• W1999444785 doi "https://doi.org/10.1210/jc.2013-1149" @default.
• W1999444785 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3644605" @default.
• W1999444785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23482611" @default.
• W1999444785 hasPublicationYear "2013" @default.
• W1999444785 type Work @default.
• W1999444785 sameAs 1999444785 @default.
• W1999444785 citedByCount "71" @default.
• W1999444785 countsByYear W19994447852013 @default.
• W1999444785 countsByYear W19994447852014 @default.
• W1999444785 countsByYear W19994447852015 @default.
• W1999444785 countsByYear W19994447852016 @default.
• W1999444785 countsByYear W19994447852017 @default.
• W1999444785 countsByYear W19994447852018 @default.
• W1999444785 countsByYear W19994447852019 @default.
• W1999444785 countsByYear W19994447852020 @default.
• W1999444785 countsByYear W19994447852021 @default.
• W1999444785 countsByYear W19994447852022 @default.
• W1999444785 countsByYear W19994447852023 @default.
• W1999444785 crossrefType "journal-article" @default.
• W1999444785 hasAuthorship W1999444785A5005079343 @default.
• W1999444785 hasAuthorship W1999444785A5035260029 @default.
• W1999444785 hasAuthorship W1999444785A5039851000 @default.
• W1999444785 hasAuthorship W1999444785A5041657790 @default.
• W1999444785 hasAuthorship W1999444785A5042928667 @default.
• W1999444785 hasAuthorship W1999444785A5055948934 @default.
• W1999444785 hasAuthorship W1999444785A5064422018 @default.
• W1999444785 hasAuthorship W1999444785A5091104216 @default.
• W1999444785 hasBestOaLocation W19994447851 @default.
• W1999444785 hasConcept C11960822 @default.
• W1999444785 hasConcept C126322002 @default.
• W1999444785 hasConcept C134018914 @default.
• W1999444785 hasConcept C170493617 @default.
• W1999444785 hasConcept C185592680 @default.
• W1999444785 hasConcept C202751555 @default.
• W1999444785 hasConcept C2776652619 @default.
• W1999444785 hasConcept C2777608072 @default.
• W1999444785 hasConcept C2780381497 @default.
• W1999444785 hasConcept C526584372 @default.
• W1999444785 hasConcept C55493867 @default.
• W1999444785 hasConcept C62478195 @default.
• W1999444785 hasConcept C71924100 @default.
• W1999444785 hasConcept C75217442 @default.
• W1999444785 hasConcept C86803240 @default.
• W1999444785 hasConcept C95444343 @default.
• W1999444785 hasConceptScore W1999444785C11960822 @default.
• W1999444785 hasConceptScore W1999444785C126322002 @default.
• W1999444785 hasConceptScore W1999444785C134018914 @default.
• W1999444785 hasConceptScore W1999444785C170493617 @default.
• W1999444785 hasConceptScore W1999444785C185592680 @default.
• W1999444785 hasConceptScore W1999444785C202751555 @default.
• W1999444785 hasConceptScore W1999444785C2776652619 @default.
• W1999444785 hasConceptScore W1999444785C2777608072 @default.
• W1999444785 hasConceptScore W1999444785C2780381497 @default.
• W1999444785 hasConceptScore W1999444785C526584372 @default.
• W1999444785 hasConceptScore W1999444785C55493867 @default.
• W1999444785 hasConceptScore W1999444785C62478195 @default.
• W1999444785 hasConceptScore W1999444785C71924100 @default.
• W1999444785 hasConceptScore W1999444785C75217442 @default.
• W1999444785 hasConceptScore W1999444785C86803240 @default.
• W1999444785 hasConceptScore W1999444785C95444343 @default.
• W1999444785 hasIssue "5" @default.
• W1999444785 hasLocation W19994447851 @default.
• W1999444785 hasLocation W19994447852 @default.
• W1999444785 hasLocation W19994447853 @default.

• next